Detalhe da pesquisa
1.
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
Ann Surg Oncol
; 29(9): 5910-5920, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499783
2.
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Pancreatology
; 20(6): 1115-1122, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778368
3.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
4.
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.
Oncologist
; 24(5): 617-623, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409792
5.
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Cancer
; 124(3): 537-545, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044496
6.
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance).
Oncologist
; 23(8): 887-e94, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666297
7.
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.
Ann Surg
; 265(1): 192-196, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28009745
8.
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease.
Blood
; 118(11): 2970-5, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21690557
9.
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Front Immunol
; 14: 1279387, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022659
10.
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
J Clin Oncol
; 41(25): 4154-4163, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467452
11.
BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance).
Mayo Clin Proc Innov Qual Outcomes
; 5(6): 1012-1020, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34703985
12.
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
Melanoma Res
; 31(1): 27-37, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33170593
13.
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma.
Immunotherapy
; 12(13): 983-995, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32752904
14.
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).
Clin Cancer Res
; 26(4): 804-811, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558480
15.
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
Nat Commun
; 11(1): 5173, 2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057068
16.
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1.
Melanoma Res
; 29(4): 420-427, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520800
17.
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
J Am Geriatr Soc
; 67(5): 920-927, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30146695
18.
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
Leuk Lymphoma
; 48(7): 1290-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17613756
19.
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
Melanoma Res
; 27(4): 335-341, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296712
20.
Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma.
J Transl Med
; 4: 35, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16911798